Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 1
1991 2
1992 2
1993 4
1994 1
1995 2
1996 3
1997 4
1998 4
1999 2
2000 4
2001 3
2002 3
2003 1
2004 2
2005 4
2006 6
2007 4
2008 3
2009 3
2010 6
2011 4
2012 6
2013 1
2014 7
2015 3
2016 1
2017 1
2018 2
2019 4
2020 2
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Elevated carcinoma antigen 125 level"
Page 1
Variant prostate carcinoma and elevated serum CA-125.
Bilen MA, Reyes A, Bhowmick D, Maa A, Bast R Jr, Pisters LL, Lin SH, Logothetis CJ, Tu SM. Bilen MA, et al. Can J Urol. 2014 Oct;21(5):7442-8. Can J Urol. 2014. PMID: 25347368 Free PMC article.
Some patients with advanced prostate cancer were found to have elevated serum CA-125 level. MATERIALS AND METHODS: We examined the clinical history of 11 patients with castration resistant prostate cancer and an elevated serum CA-125 l …
Some patients with advanced prostate cancer were found to have elevated serum CA-125 level. MATERIALS AND METHODS: We e …
Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.
Kobayashi H. Kobayashi H. Int J Clin Oncol. 2009 Oct;14(5):378-82. doi: 10.1007/s10147-009-0931-2. Epub 2009 Oct 25. Int J Clin Oncol. 2009. PMID: 19856043 Review.
Although some endometriosis lesions may predispose to clear cell carcinoma (CCC) and endometrioid adenocarcinoma (EAC) of the ovary, both of these cancers differ from the other histological types with respect to their clinical characteristics and carcinogenesis. In …
Although some endometriosis lesions may predispose to clear cell carcinoma (CCC) and endometrioid adenocarcinoma (EAC) of the ovary, …
Primary peritoneal serous papillary carcinoma: a case series.
Blontzos N, Vafias E, Vorgias G, Kalinoglou N, Iavazzo C. Blontzos N, et al. Arch Gynecol Obstet. 2019 Oct;300(4):1023-1028. doi: 10.1007/s00404-019-05280-z. Epub 2019 Sep 5. Arch Gynecol Obstet. 2019. PMID: 31486887
PURPOSE: To present the clinical and laboratory characteristics, as well as the management, of patients with primary peritoneal serous papillary carcinoma (PPSPC). ...Two of the patients did not mention any symptomatology and the disease was suspected by an abnormal …
PURPOSE: To present the clinical and laboratory characteristics, as well as the management, of patients with primary peritoneal serou …
CA 125 may not reflect disease status in patients with uterine serous carcinoma.
Price FV, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Price FV, et al. Cancer. 1998 May 1;82(9):1720-5. doi: 10.1002/(sici)1097-0142(19980501)82:9<1720::aid-cncr19>3.0.co;2-6. Cancer. 1998. PMID: 9576294
BACKGROUND: Although CA 125 level correlates with response to therapy in patients with serous carcinoma of the ovary, the utility of CA 125 in patients with high risk or metastatic endometrial carcinoma has not been established. ...One patient w …
BACKGROUND: Although CA 125 level correlates with response to therapy in patients with serous carcinoma of the ovary, t …
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications.
Chen W, Zhong S, Shan B, Zhou S, Wu X, Yang H, Ye S. Chen W, et al. J Ovarian Res. 2020 Aug 8;13(1):89. doi: 10.1186/s13048-020-00693-w. J Ovarian Res. 2020. PMID: 32771026 Free PMC article.
BACKGROUND: This study attempts to evaluate whether preoperative systemic inflammatory response (SIR) markers or other hematological variables, such as albumin, D-dimer, and carbohydrate antigen 125, play roles in predicting chemotherapy response and survival outcom …
BACKGROUND: This study attempts to evaluate whether preoperative systemic inflammatory response (SIR) markers or other hematological variabl …
Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literature.
Kalluri M, Judson MA. Kalluri M, et al. Am J Med Sci. 2007 Dec;334(6):441-3. doi: 10.1097/MAJ.0b013e3180f60bc4. Am J Med Sci. 2007. PMID: 18091365 Review.
METHODS: We describe a patient with active sarcoidosis and an elevated serum CA 125 level at our institution. A search of medical databases revealed 4 additional cases of sarcoidosis associated with elevated serum CA 125 levels. ...Four o …
METHODS: We describe a patient with active sarcoidosis and an elevated serum CA 125 level at our institution. A search …
Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer.
Clevers MR, Kastelijn EA, Peters BJM, Kelder H, Schramel FMNH. Clevers MR, et al. Anticancer Res. 2021 Feb;41(2):869-876. doi: 10.21873/anticanres.14839. Anticancer Res. 2021. PMID: 33517292
BACKGROUND/AIM: Treatment options for advanced non-small cell lung cancer (NSCLC) include immunotherapy. Elevated carcinoembryonic antigen (CEA) and cancer antigen 125 (Ca-125) levels are associated with poorer prognoses of resected NSCLC …
BACKGROUND/AIM: Treatment options for advanced non-small cell lung cancer (NSCLC) include immunotherapy. Elevated carcinoembryonic …
CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study.
Tian C, Markman M, Zaino R, Ozols RF, McGuire WP, Muggia FM, Rose PG, Spriggs D, Armstrong DK. Tian C, et al. Cancer. 2009 Apr 1;115(7):1395-403. doi: 10.1002/cncr.24152. Cancer. 2009. PMID: 19195045 Free PMC article. Review.
BACKGROUND: There are limited data regarding unique clinical or laboratory features associated with advanced clear cell (CC) and mucinous (MU) epithelial ovarian cancers (EOC), particularly the relationship between CA-125 antigen levels and prognosis. …
BACKGROUND: There are limited data regarding unique clinical or laboratory features associated with advanced clear cell (CC) and muci …
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Hørding U, Toftager-Larsen K, Dreisler A, Lund B, Daugaard S, Lundvall F, Arends J, Winkel P, Rørth M. Hørding U, et al. Gynecol Obstet Invest. 1990;30(3):178-83. doi: 10.1159/000293261. Gynecol Obstet Invest. 1990. PMID: 2265805
Three different tumor markers, placental alkaline phosphatase (PLAP), tissue polypeptide antigen (TPA), and cancer antigen 125 (CA 125), were measured in serum samples obtained during chemotherapy in 57 ovarian carcinoma patients. ...TPA serum …
Three different tumor markers, placental alkaline phosphatase (PLAP), tissue polypeptide antigen (TPA), and cancer antigen …
Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety.
Liu D, Wang J, Ma Z, Zhang N, Zhao Y, Yang X, Wen Z, Xie H. Liu D, et al. Cardiovasc Intervent Radiol. 2022 Aug;45(8):1092-1101. doi: 10.1007/s00270-022-03108-z. Epub 2022 May 19. Cardiovasc Intervent Radiol. 2022. PMID: 35588011
Cox analysis demonstrated that combined therapy (adjuvant sorafenib after DEB-TACE) and a low cancer antigen (CA) 125 level ( 35 U/ml) were independent favourable prognostic factors. Transient elevation of the aminotransferase level, nausea, vom …
Cox analysis demonstrated that combined therapy (adjuvant sorafenib after DEB-TACE) and a low cancer antigen (CA) 125 level …
93 results